Chufeng Zhang

836 total citations
28 papers, 711 citations indexed

About

Chufeng Zhang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chufeng Zhang has authored 28 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chufeng Zhang's work include Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Chufeng Zhang is often cited by papers focused on Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Chufeng Zhang collaborates with scholars based in China and Singapore. Chufeng Zhang's co-authors include Yang Peng, Zhao Deng, Wei Zhu, Qin Li, Yuebin Lian, Rongxiang Chen, Xing Zhu, Xian Li, Yanhui Su and Shuao Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Catalysis B: Environmental and Journal of Medicinal Chemistry.

In The Last Decade

Chufeng Zhang

27 papers receiving 702 citations

Peers

Countries citing papers authored by Chufeng Zhang

Since Specialization

Citations

This map shows the geographic impact of Chufeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chufeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chufeng Zhang more than expected).

Fields of papers citing papers by Chufeng Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chufeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chufeng Zhang. The network helps show where Chufeng Zhang may publish in the future.

Co-authorship network of co-authors of Chufeng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Chufeng Zhang. A scholar is included among the top collaborators of Chufeng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chufeng Zhang. Chufeng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Harnessing diatoms for sustainable economy: Integrating metabolic mechanism with wastewater treatment, biomass production and applications 2025 ·Algal Research ·Chufeng Zhang, Yuxuan Wu, Mingchu Zhang, Zhaoyang Li, Tian Xing, (unknown), Jun Huang, Cong Li	0
2	Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer 2024 ·European Journal of Medicinal Chemistry ·(unknown), Rui Wu, (unknown), (unknown), (unknown), Xue Cui, Yong Li, Chufeng Zhang, (unknown), Zhiyuan Fu, (unknown), Jie Liu, Lijuan Chen	1
3	Structure-based design and synthesis of BML284 derivatives: A novel class of colchicine-site noncovalent tubulin degradation agents 2024 ·European Journal of Medicinal Chemistry ·Chufeng Zhang, Wei Yan, (unknown), Minghai Tang, (unknown), Fang Wang, (unknown), Min Zhao, Jianhong Yang, Yong Li	5
4	Design, synthesis and biological evaluation of purine-based derivatives as novel JAK2/BRD4(BD2) dual target inhibitors 2023 ·Bioorganic Chemistry ·Yong Guo, Yurong Zou, Yong Chen, (unknown), Zihao Zhang, (unknown), Minghai Tang, Tao Yang, (unknown), Chufeng Zhang, (unknown), (unknown), Shunjie Zhang, Bin Peng, Dingguo Xu, Lijuan Chen	12
5	Discovery, Optimization, and Evaluation of Potent and Selective DNA-PK Inhibitors in Combination with Chemotherapy or Radiotherapy for the Treatment of Malignancies 2023 ·Journal of Medicinal Chemistry ·(unknown), Xue Yuan, Tao Yang, (unknown), Yong Chen, Minghai Tang, Chufeng Zhang, Yurong Zou, Shunjie Zhang, Dan Dan Li, Mingsong Shi, (unknown), (unknown), Min Zhao, Zhuang Yang, Lijuan Chen	7
6	Discovery and Evaluation of 3-Quinoxalin Urea Derivatives as Potent, Selective, and Orally Available ATM Inhibitors Combined with Chemotherapy for the Treatment of Cancer via Goal-Oriented Molecule Generation and Virtual Screening 2023 ·Journal of Medicinal Chemistry ·(unknown), Yingxue Yang, Yurong Zou, (unknown), Chufeng Zhang, Minghai Tang, Tao Yang, Yong Chen, (unknown), (unknown), Shunjie Zhang, (unknown), (unknown), Qing Xu, Wen He, Dingguo Xu, (unknown), Lijuan Chen	14
7	Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study 2023 ·Acta Oncologica ·(unknown), Sumei Li, Chufeng Zhang, (unknown), Kaili Chen, Zhenshu Xu	4
8	Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs) 2022 ·Journal of Medicinal Chemistry ·(unknown), Yong Chen, Minghai Tang, (unknown), Mingsong Shi, Yingxue Yang, (unknown), Tao Yang, Jiang Liu, (unknown), (unknown), Chufeng Zhang, Lijuan Chen	14
9	Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents 2022 ·Journal of Medicinal Chemistry ·Yong Li, Yan Liu, (unknown), Wei Yan, Chufeng Zhang, Zhuang Yang, Peng Bai, Minghai Tang, Mingsong Shi, Wen He, (unknown), Jiang Liu, Kai Han, (unknown), (unknown), Haoyu Ye, Jianhong Yang, Lijuan Chen	19
10	Discovery, Optimization, and Evaluation of Potent and Selective PI3Kδ-γ Dual Inhibitors for the Treatment of B-cell Malignancies 2022 ·Journal of Medicinal Chemistry ·(unknown), Wei Zheng, Yong Chen, Minghai Tang, Dan Li, (unknown), Tao Yang, Chufeng Zhang, Jiang Liu, (unknown), Mingsong Shi, (unknown), (unknown), (unknown), Min Zhao, Lijuan Chen	5
11	Discovery of 3-(4-(2-((1H-Indol-5-yl)amino)-5-fluoropyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel Disease 2021 ·Journal of Medicinal Chemistry ·Chufeng Zhang, (unknown), Yong Li, Minghai Tang, Tao Yang, (unknown), Yong Chen, (unknown), Mingli Xiang, Lijuan Chen	16
12	Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases 2021 ·Journal of Medicinal Chemistry ·(unknown), Dan Li, Wei Zheng, Mingsong Shi, Yong Chen, Minghai Tang, Tao Yang, Min Zhao, (unknown), Chufeng Zhang, Jiang Liu, (unknown), Zhuang Yang, Lijuan Chen	30
13	Immune Checkpoint Inhibitors Plus Anlotinib Versus Anlotinib Alone as Third-Line Treatment in Advanced Non-Small-Cell Lung Cancer: A Retrospective Study 2021 ·Future Oncology ·(unknown), Chufeng Zhang, Shengjie Yang, Qing Chen, Chen Wang, Qisen Guo	8
14	Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms 2019 ·Journal of Medicinal Chemistry ·Tao Yang, (unknown), (unknown), Zhuang Yang, Minghai Tang, Jun He, Yong Chen, Peng Bai, Xue Yuan, Chufeng Zhang, (unknown), (unknown), Mingli Xiang, Lijuan Chen	31
15	Copper-based Conductive Metal Organic Framework <i>In-situ</i> Grown on Copper Foam as a Bifunctional Electrocatalyst 2019 ·Acta Physico-Chimica Sinica ·Chufeng Zhang, (unknown), Yuebin Lian, Yujie Chen, Qin Li, Yindong Gu, (unknown), Zhao Deng, Yang Peng	14
16	Electrostatic charge transfer for boosting the photocatalytic CO2 reduction on metal centers of 2D MOF/rGO heterostructure 2019 ·Applied Catalysis B: Environmental ·Qiaoqiao Mu, Wei Zhu, Xian Li, Chufeng Zhang, Yanhui Su, Yuebin Lian, Pengwei Qi, Zhao Deng, Duo Zhang, Shuao Wang, Xing Zhu, Yang Peng	215
17	Design, synthesis, and SAR study of highly potent, selective, irreversible covalent JAK3 inhibitors 2018 ·Molecular Diversity ·Linhong He, Mingfeng Shao, Taijin Wang, (unknown), Chufeng Zhang, Lijuan Chen	14
18	Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer 2016 ·OncoTargets and Therapy ·Qisen Guo, Yan Guan, Xiuju Liu, Chufeng Zhang, Peng Wang, H. Liang, (unknown)	15
19	Progress of Circulating Tumor Cells in Cancer Management 2015 ·Technology in Cancer Research & Treatment ·Chufeng Zhang, Lijie Wang, Yan Guan, (unknown), Xiuju Liu, (unknown), Qisen Guo	4
20	Optimal Timing of Radiotherapy with Alternating/Sequential Radio-Chemotherapy for Limited-stage Small Cell Lung Cancer 2014 ·Asian Pacific Journal of Cancer Prevention ·Lijie Wang, Xiuju Liu, Yan Guan, Chufeng Zhang, Peng Wang, Yan Li, Qisen Guo	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact